1. S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA). (23rd June 2022) Authors: Infante, M. S.; Salmanton-García, J.; Fernandez-Cruz, A.; Marchesi, F.; RÁČIL, Z.; Hanakova, M.; Jaksic, O.; Weinbergerova, B.; Besson, C.; Duarte, R.; Itri, F.; VALKOVIĆ, T.; Busca, A.; Guidetti, A.; GLENTHØJ, A.; Collins, G.; Bonuomo, V.; Sili, U.; Seval, G.; Machado, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗